Related Experiment Video
Updated: Aug 11, 2026
Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models
Published on: April 1, 2022
Diagnostic quality in hysterosalpingography. Comparison between iodixanol and iotrolan
S Lindequist1, F Rasmussen, H H Madsen
1Department of Radiology, Esbjerg Central Hospital, Denmark.
Insights
This study found that both iodixanol and iotrolan contrast media offer equal diagnostic quality and safety for hysterosalpingography (HSG). No significant differences were observed in image quality or adverse events between the two agents.
Area of Science:
- Radiology
- Diagnostic Imaging
- Gynecological Imaging
Background:
- Hysterosalpingography (HSG) is a key diagnostic procedure in gynecology.
- Selection of appropriate contrast media is crucial for optimal HSG outcomes.
- Iodixanol and iotrolan are water-soluble, non-ionic, iso-osmolar dimeric contrast agents with similar properties.
Purpose of the Study:
- To compare the diagnostic quality of iodixanol and iotrolan in HSG.
- To evaluate and compare adverse events associated with these two contrast media during HSG procedures.
Main Methods:
- A double-blind, randomized, parallel-group, phase-III study involving 120 patients.
- Diagnostic quality assessed via visual analogue scale and categorical rating of specific regions.
- Patient-reported outcomes collected through questionnaires and interviews.
Main Results:
- Overall diagnostic quality was equivalent between iodixanol and iotrolan groups.
- No statistically significant differences in diagnostic quality were found in specific regions of interest.
- Adverse event profiles were comparable between the two contrast media, with no significant differences noted.
Conclusions:
- Both iodixanol and iotrolan demonstrate high diagnostic quality for hysterosalpingography.
- The choice between iodixanol and iotrolan for HSG does not appear to impact diagnostic image quality or patient safety based on this study.
Purpose:
To compare the diagnostic quality and adverse events of the water-soluble, non-ionic, iso-osmolar, dimeric contrast media iodixanol and iotrolan in hysterosalpingography (HSG).
Material And Methods:
One hundred and twenty patients participated in a double-blind randomized parallel-group phase-III study. Questionnaires and patient interviews were used. Diagnostic quality was assessed using a visual analogue scale and the quality in specific regions was rated using a categorical scale.
Results:
Overall diagnostic quality was equal for the two groups. There was no statistically significant difference between the two groups in diagnostic quality in the specific regions of interest. No differences between the contrast media were found with regard to adverse events.
Conclusion:
Both contrast media provided images of high diagnostic quality in HSG.
